Trials / Terminated
TerminatedNCT02133534
The Effect of Atorvastatin on Endothelial Cell Dysfunction in Chronic Kidney Disease
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 1 (actual)
- Sponsor
- Duke University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to see if patients with chronic kidney disease have endothelial cells that don't function properly, which is thought to be a marker for cardiovascular risk. Endothelial cells line the heart and blood vessels. The investigators will treat your high cholesterol with a cholesterol-lowering drug (atorvastatin, or Lipitor). They will determine if this cholesterol lowering drug improves subjects' cholesterol as well as the function of endothelial cells.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atorvastatin |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2009-05-01
- Completion
- 2009-05-01
- First posted
- 2014-05-08
- Last updated
- 2014-07-03
- Results posted
- 2014-07-03
Source: ClinicalTrials.gov record NCT02133534. Inclusion in this directory is not an endorsement.